A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
Clinical trial NCT06289504 · COMPLETED
Trial details
- NCT number
- NCT06289504
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-27
- Primary completion
- 2024-10-16
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.